[
  {
    "ts": null,
    "headline": "Stifel downgrades Biogen on slow Alzheimer’s drug launch, uncertainty ahead",
    "summary": "Investing.com -- Stifel downgraded Biogen Inc (NASDAQ:BIIB) stock to “hold” from “buy” as it noted the company was grappling with a challenging year due to a slow rollout of its Alzheimer’s drug, lecanemab.",
    "url": "https://finnhub.io/api/news?id=e5b867040d470989a2c1ce2627978dbd8f7b0ced42cae21bd1dc3f61c63f835c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734372966,
      "headline": "Stifel downgrades Biogen on slow Alzheimer’s drug launch, uncertainty ahead",
      "id": 132014537,
      "image": "https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png",
      "related": "BIIB",
      "source": "Yahoo",
      "summary": "Investing.com -- Stifel downgraded Biogen Inc (NASDAQ:BIIB) stock to “hold” from “buy” as it noted the company was grappling with a challenging year due to a slow rollout of its Alzheimer’s drug, lecanemab.",
      "url": "https://finnhub.io/api/news?id=e5b867040d470989a2c1ce2627978dbd8f7b0ced42cae21bd1dc3f61c63f835c"
    }
  },
  {
    "ts": null,
    "headline": "Netflix, Ford, Biogen: Trending tickers",
    "summary": "Morning Brief anchors Seana Smith and Brad Smith discuss Wall Street's latest stock analyst recommendations. Loop Capital downgraded Netflix (NFLX) stock to Hold from Buy while raising the price target to $950 per share, arguing the stock is approaching fair value. Meanwhile, Oppenheimer analysts raised their price target to $1,065 per share, highlighting the company's expansion into live events. Ford (F) shares declined after Jefferies downgraded the automaker to Underperform from Hold. The firm cited several challenges, including inventory overhang and strategic complexities surrounding its European business operations. Additionally, Stifel analysts reduced Biogen's (BIIB) rating to Hold from Buy, noting an absence of clinical catalysts for the upcoming year. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here. This post was written by Angel Smith",
    "url": "https://finnhub.io/api/news?id=c1c49cf301f9dc1eb2f5a16754cb148b6e23a89312aebb85e116a2f780c371d9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734362801,
      "headline": "Netflix, Ford, Biogen: Trending tickers",
      "id": 132012860,
      "image": "https://s.yimg.com/ny/api/res/1.2/l7biPs1A7i8mm29QkrJ3Ug--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzQ-/https://s.yimg.com/os/creatr-uploaded-images/2024-12/4e437260-bbc1-11ef-a77e-b166291dc313",
      "related": "BIIB",
      "source": "Yahoo",
      "summary": "Morning Brief anchors Seana Smith and Brad Smith discuss Wall Street's latest stock analyst recommendations. Loop Capital downgraded Netflix (NFLX) stock to Hold from Buy while raising the price target to $950 per share, arguing the stock is approaching fair value. Meanwhile, Oppenheimer analysts raised their price target to $1,065 per share, highlighting the company's expansion into live events. Ford (F) shares declined after Jefferies downgraded the automaker to Underperform from Hold. The firm cited several challenges, including inventory overhang and strategic complexities surrounding its European business operations. Additionally, Stifel analysts reduced Biogen's (BIIB) rating to Hold from Buy, noting an absence of clinical catalysts for the upcoming year. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here. This post was written by Angel Smith",
      "url": "https://finnhub.io/api/news?id=c1c49cf301f9dc1eb2f5a16754cb148b6e23a89312aebb85e116a2f780c371d9"
    }
  },
  {
    "ts": null,
    "headline": "Are You a Value Investor? This 1 Stock Could Be the Perfect Pick",
    "summary": "The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.",
    "url": "https://finnhub.io/api/news?id=56554951293025d8fabf2768155980d09431875dcb4c276a497caca6987dfab2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734360011,
      "headline": "Are You a Value Investor? This 1 Stock Could Be the Perfect Pick",
      "id": 132014539,
      "image": "https://media.zenfs.com/en/zacks.com/b95cfdd8768bc3c4620e666dbcb0b248",
      "related": "BIIB",
      "source": "Yahoo",
      "summary": "The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.",
      "url": "https://finnhub.io/api/news?id=56554951293025d8fabf2768155980d09431875dcb4c276a497caca6987dfab2"
    }
  },
  {
    "ts": null,
    "headline": "American Century Ultra Fund Q3 2024 Commentary",
    "summary": "The broad U.S. stock market posted solid gains that saw a reversal of trends from the first half of the year. Click here to read the full commentary.",
    "url": "https://finnhub.io/api/news?id=30d50aff6e121c21c73f070a2cf619d16f40363f6bcf0607404d1f906adf3825",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734350100,
      "headline": "American Century Ultra Fund Q3 2024 Commentary",
      "id": 132012715,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1160928890/image_1160928890.jpg?io=getty-c-w1536",
      "related": "BIIB",
      "source": "SeekingAlpha",
      "summary": "The broad U.S. stock market posted solid gains that saw a reversal of trends from the first half of the year. Click here to read the full commentary. ",
      "url": "https://finnhub.io/api/news?id=30d50aff6e121c21c73f070a2cf619d16f40363f6bcf0607404d1f906adf3825"
    }
  }
]